To determine whether the increased CD4+ T cell activation in SLE would result in upregulation of Foxp3 in non-Treg cells, we isolated PBMCs from whole blood samples obtained from eight patients being treated for SLE. This evidence concerns the gene FOXP3 and systemic lupus erythematosus.